Log In
follow
/americas/log-in/
Subscribe
follow
/americas/subscribe/
Contact
follow
/americas/contact/
How to Invest
follow
/americas/how-to-invest/
Americas
follow
/americas/
Europe, Middle East, Africa
follow
/europe/
Australia, New Zealand
follow
/australia/
Log In
follow
/americas/log-in/
Subscribe
follow
/americas/subscribe/
Contact
follow
/americas/contact/
How to Invest
follow
/americas/how-to-invest/
Americas
follow
/americas/
Europe, Middle East, Africa
follow
/europe/
Australia, New Zealand
follow
/australia/
About GMO
follow
/americas/about-gmo/
Our Approach
follow
/americas/about-gmo/our-approach/
Our Clients
follow
/americas/about-gmo/our-clients/
ESG Capabilities
follow
/americas/about-gmo/esg-capabilities/
News and Media
follow
/americas/about-gmo/news-and-media/
Investment Capabilities
follow
/americas/investment-capabilities/
Strategies
follow
/americas/investment-capabilities/strategies/
Mutual Funds
follow
/americas/investment-capabilities/mutual-funds/
Private Funds
follow
/americas/investment-capabilities/private-funds/
Document Library
follow
/americas/document-library/
How to Invest
follow
/americas/how-to-invest/
Research Library
follow
/americas/research-library/
People
follow
/americas/people/
Investment Teams
follow
/americas/people/investment-teams/
Firm Management
follow
/americas/people/firm-management/
Relationship Team
follow
/americas/people/relationship-team/
Board of Directors
follow
/americas/people/board-of-directors/
Careers
follow
/americas/careers/
Institutions
follow
/americas/institutions/
Family Offices
follow
/americas/family-offices/
Consultants
follow
/americas/consultants/
Intermediaries & Wealth Managers
follow
/americas/intermediairies--wealth-managers/
Our People
follow
/americas/people/
Our Clients
follow
/americas/about-gmo/our-clients/
Our Approach
follow
/americas/about-gmo/our-approach/
Careers
follow
/americas/careers/
Multi-Asset Class
follow
/americas/investment-capabilities/?asset_class=943b2ed5-9cbf-4002-b9af-838b7fd66c49
Equities
follow
/americas/investment-capabilities/?asset_class=905e3bb9-d230-437f-94a3-44da1562c08c
Alternatives
follow
/americas/investment-capabilities/?asset_class=6545ad64-534a-4e9b-a8a8-d170632d07bb
Fixed Income
follow
/americas/investment-capabilities/?asset_class=f3e5a9b6-aa9d-43b9-9d64-48ba2c113c22
The GMO Quarterly Letter
follow
/americas/research-library/1q-2021-gmo-quarterly-letter/
GMO 7-Year Asset Class Forecast
follow
/americas/research-library/gmo-7-year-asset-class-forecast-3q-2021/
Research Library
follow
/americas/research-library/
Read Part 1
follow
/americas/research-library/part-1-inflation--tall-tales-and-true-causes/
Read Part 2
follow
/americas/research-library/part-2-what-to-do-in-the-case-of-sustained-inflation/
GMO’s latest Quarterly Letter
follow
/americas/research-library/2q-2021-gmo-quarterly-letter/
Read the letter
follow
/americas/research-library/2q-2021-gmo-quarterly-letter/
Equity Dislocation Strategy
follow
/americas/product-index-page/alternatives/equity-dislocation-strategy/
Jeremy’s full viewpoint about the current bubble
follow
/americas/research-library/waiting-for-the-last-dance/
shortlisted for the 2021 PRI Awards
follow
https://www.unpri.org/showcasing-leadership/shortlists-for-the-pri-awards-2021/8266.article
Read about how we integrated ESG into our investment analysis
follow
/americas/research-library/sovereign-esg-integration/
Read our recent research
follow
/americas/research-library/quality-investing-and-inflation/
GMO’s Quality Strategy
follow
/americas/product-index-page/equities/quality-strategy/
Insights Learning to Live with Covid-19 By Focused Equity Team October 15, 2021 When we invested in “reopening” stocks, we posited that the world would get over Covid-19 by one of three routes: treatment, vaccination, or learning to live with it. It turns out that the answer lay in a blend of all three. Read More
follow
/americas/research-library/learning-to-live-with-covid-19/
Insights Growth Bubble: Making Money on Companies That... By Asset Allocation Team October 12, 2021 Every bubble is unique, but they all share common threads. Making money on companies that make no money is never a good sign when it is done this pervasively and at these valuations. Read More
follow
/americas/research-library/growth-bubble-making-money-on-companies-that-make-no-money/
White Papers Part 2: What to Do in the Case of Sustained I... By James Montier and Philip Pilkington September 21, 2021 We look at various instruments that might be thought to protect your portfolio from an inflationary outcome, whether as an inflation hedge or as a store of value. Read More
follow
/americas/research-library/part-2-what-to-do-in-the-case-of-sustained-inflation/
GMO Quarterly Letter 2Q 2021 GMO Quarterly Letter By Ben Inker August 31, 2021 Ben Inker addresses some of the objections we hear from investors who are hesitant to join us in betting strongly on value today. Read More
follow
/americas/research-library/2q-2021-gmo-quarterly-letter/
Insights Merger Arbitrage Opportunity By Asset Allocation Team August 27, 2021 The remarkable selloff in the merger arbitrage space over the last month has led to compelling opportunity for long-term investors. Read More
follow
/americas/research-library/merger-arbitrage-opportunity/
White Papers Part 1: Inflation – Tall Tales and True Cause... By James Montier and Philip Pilkington August 12, 2021 Learn more about the underlying causes of inflation and why we believe the recent upsurge in inflationary angst is likely much ado about nothing. Read More
follow
/americas/research-library/part-1-inflation--tall-tales-and-true-causes/
Quarterly EM Debt Update Valuation Metrics in Emerging Debt: 2Q 2021 By Emerging Country Debt Team August 12, 2021 As we enter Q3, our valuation metrics for emerging debt are less compelling than they were at the beginning of the quarter. In this piece, we update our valuation charts and commentary. Read More
follow
/americas/research-library/valuation-metrics-in-emerging-debt-2q-2021/
Insights Japan Small Value By Usonian Japan Equity and Asset Allocation Team July 30, 2021 The Asset Allocation and Usonian Japan Equity teams comment on opportunities in Japan and why Japan small value holds the top spot among equities in GMO’s 7-Year Asset Class Forecasts. Read More
follow
/americas/research-library/japan-small-value/
Read More GMO Research
follow
/americas/research-library/
Privacy Notice
follow
/americas/privacy-notice/
Terms and Conditions
follow
/americas/terms-and-conditions/
Benchmark Disclaimers
follow
/americas/benchmark-disclaimers/
Legal & Compliance
follow
/americas/legal-and-compliance/
Web Fraud & Phishing Warning
follow
/americas/web-fraud-and-phishing-warning/
About GMO
follow
/americas/about-gmo/
Investment Capabilities
follow
/americas/investment-capabilities/
How to Invest
follow
/americas/how-to-invest/
Research Library
follow
/americas/research-library/
People
follow
/americas/people/
Careers
follow
/americas/careers/
Institutions
follow
/americas/institutions/
Family Offices
follow
/americas/family-offices/
Consultants
follow
/americas/consultants/
Intermediaries & Wealth Managers
follow
/americas/intermediairies--wealth-managers/
Log In
follow
/americas/log-in/
Subscribe
follow
/americas/subscribe/
Contact
follow
/americas/contact/
How to Invest
follow
/americas/how-to-invest/
.st0{clip-path:url(#SVGID_2_);} .st1{clip-path:url(#SVGID_4_);} .st2{clip-path:url(#SVGID_6_);} .st3{clip-path:url(#SVGID_8_);} .st4{clip-path:url(#SVGID_10_);} .st5{clip-path:url(#SVGID_12_);} .st6{fill:#FFFFFF;stroke:#478976;stroke-width:0.75;stroke-miterlimit:10;} .st7{fill:#478976;}Togetstartedright away,justtapanyplaceholdertext(such asthis)andstarttypingto replaceit withyourown.Togetstartedright away,justtapanyplaceholdertext(such asthis)andstarttypingto replaceit withyourown.
follow
https://www.linkedin.com/company/gmo/
.cls-1{fill:#fff;stroke:#478976;stroke-miterlimit:10;stroke-width:0.75px;}.cls-2{fill:#478976;}
follow
https://twitter.com/GMOInsights
Privacy Notice
follow
/americas/privacy-notice/
Terms and Conditions
follow
/americas/terms-and-conditions/
Benchmark Disclaimers
follow
/americas/benchmark-disclaimers/
Legal & Compliance
follow
/americas/legal-and-compliance/
Web Fraud & Phishing Warning
follow
/americas/web-fraud-and-phishing-warning/